Hansa Biopharma — Major Shareholding Notification 2017

Dec 29, 2017

Issuer Hansa Biopharma AB

Holder

NEXTTOBE AB

Instrument

Instrument	Ordinary shares SE0002148817
Before the transaction
Shares	9,443,761
Voting rights	9,443,761
Transaction
Reason for major shareholding notification Corporate action
Date	29/12/2017
Limit for number of shares	25 %
Limit for number of votes	25 %
After the transaction
Quantity
Shares	9,443,761
Directly held voting rights	9,443,761
Indirectly held voting rights	0
Percentage
Directly held shares	24.71646 %
Directly held voting rights	24.95215 %
Indirectly held voting rights	0 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	24.95215 %	9,443,761
Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled - Cash settled
Total	24.95215 %	9,443,761
Group total holdings
Voting rights 9,443,761 Percentage of voting rights 24.95215
Published
Contact
Name Erika Kjellberg Eriksson
29/12/2017 15:02
CLOSE PRINT

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25